A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Condition:   Asthma
Interventions:   Drug: Placebo;   Drug: Albuterol Spiromax®
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified October 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.